CSL Behring commissioned The Economist Intelligence Unit to study rare disease care in the Asia-Pacific region. The results, released in July, showed that far too many patients don’t get the best, evidence-based care. This infographic explores key findings in the white paper.
Learn more about “Suffering in Silence” and how 258 million rare disease patients receive care.
